10 results
S-3
EX-1.2
VERV
Verve Therapeutics Inc
1 Jul 22
Shelf registration
4:36pm
, accounting, regulatory and tax advisors to the extent it deemed appropriate.
(c) Research Analyst Independence. The Company acknowledges that the Agent’s
DEF 14A
VERV
Verve Therapeutics Inc
29 Apr 22
Definitive proxy
7:01am
Policy and Procedures
REPORT OF THE AUDIT COMMITTEE
CORPORATE GOVERNANCE
Director Nomination Process
Board Diversity Matrix
Director Independence
Board … -approval of audit and non-audit services for the purpose of maintaining the independence of our independent auditor. We may not engage our independent
10-K
kkaepwut06
14 Mar 22
Annual report
7:04am
424B4
e74uoc36pvdn1ezvc
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
5m2kmldowv0i
14 Jun 21
IPO registration (amended)
6:15am
S-1
t7p kpqa89xfkrbxu
28 May 21
IPO registration
4:04pm
DRS
pc1 6qffbl
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next